June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Endophthalmitis following intravitreal injection: spectrum of causative organisms and antimicrobial susceptibility
Author Affiliations & Notes
  • Grace Peng
    Ophthalmology, UNIFESP- Federal University of São Paulo, Sao Paulo, Brazil
  • Paulo Bispo
    Ophthalmology, UNIFESP- Federal University of São Paulo, Sao Paulo, Brazil
  • Maria Cecilia Yu
    Ophthalmology, UNIFESP- Federal University of São Paulo, Sao Paulo, Brazil
  • Ana Luisa Hofling-Lima
    Ophthalmology, UNIFESP- Federal University of São Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships Grace Peng, None; Paulo Bispo, None; Maria Cecilia Yu, None; Ana Luisa Hofling-Lima, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1105. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Grace Peng, Paulo Bispo, Maria Cecilia Yu, Ana Luisa Hofling-Lima; Endophthalmitis following intravitreal injection: spectrum of causative organisms and antimicrobial susceptibility. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1105.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To describe patient demographics and microbiological features of patients with clinically diagnosed endophthalmitis following intravitreal injection

 
Methods
 

Retrospective review of consecutive cases of endophthalmitis seen at a university referral center between January 2005 and August 2012

 
Results
 

Thirty one eyes from 31 patients presented clinically diagnosed endophthalmitis following intravitreal injection in the study period. Most patients were women (58%) and the mean age was 68 ± 10.34 years old. The majority of the patients received injections of bevacizumab (61.3%) followed by steroids (16.12%), ranibizumab (3.22%) and miscellaneous (19.35%). Overall, the positivity of bacterial culture was 48.4% (15 out of 31 patients). The higher culture positivity was achieved for vitreous from vitrectomy (55.5%; 5/9) and vitreous tap samples (47.8%; 11/23). Aqueous humor was culture positive in 14.3% (2/14) of the samples. At the time of sample collection, at least 9 out of 15 patients were in use of topical fluoroquinolone (for the remaining information was not available). The most common organism isolated was coagulase-negative Staphylococci - CoNS (73.3%; 11/15) followed by S. aureus (20%; 3/15) and viridans group Streptococci (6.6%; 1/15). Gatifloxacin (GAT) and moxifloxacin (MOX) susceptibility rate was 80% (MIC90 2 µg/mL) among all bacterial isolates. All S. aureus isolates were susceptible to fourth-generation fluoroquinolone, methicillin and vancomycin. For CoNS, 72.7% of isolates were susceptible to GAT and MOX (MIC90 4µg/mL for both). The frequency of methicillin-resistant CoNS (MRCoNS) was 36.3% (4/11). Only MRCoNS isolates demonstrated resistance to fourth-generation fluoroquinolones (75%; 3/4). All CoNS isolates were susceptible to vancomycin.

 
Conclusions
 

Culture-proven endophthalmitis following intravitreal injection was documented in the last 7 years for 15 patients in our setting. Staphylococci remained as the main causative organism and was isolated even from patients using post-injection topical fluoroquinolones. The frequency of endophthalmitis was higher among the patients that received bevacizumab intravitreal injection, probably due to the greater number of this type of injection.

     
Keywords: 513 endophthalmitis • 561 injection • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×